Rx Safes, Inc. has been named winning bidder of a solicitation issued by the Oklahoma Bureau of Narcotics and Dangerous Drugs Control. The company has received a Purchase Order issued by the Bureau for 500 units of the Rx DrugSAFE, which will be given to at risk families in the State.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2018 | GeneSYS ID, Inc. cancelled the transaction announced on October 7, 2015 | CI |
2017 | GeneSYS ID, Inc. Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 19 | |
-31.05% | 1.43B | |
+168.41% | 149M | |
+28.30% | 133M |
- Stock Market
- Equities
- GNID Stock
- News GeneSYS ID, Inc.
- Rx Safes Wins Bid from Oklahoma Bureau Of Narcotics